DICERNA PHARMACEUTICALS Trademark

Trademark Overview


On Wednesday, May 16, 2018, a trademark application was filed for DICERNA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the DICERNA PHARMACEUTICALS trademark a serial number of 87924207. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 31, 2022. This trademark is owned by Dicerna Pharmaceuticals, Inc.. The DICERNA PHARMACEUTICALS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies

Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
dicerna pharmaceuticals

General Information


Serial Number87924207
Word MarkDICERNA PHARMACEUTICALS
Filing DateWednesday, May 16, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 31, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 30, 2018

Trademark Statements


Description of MarkThe mark consists of a vertical double helix positioned to the left of the words "DICERNA PHARMACEUTICALS". The word "DICERNA" is stacked directly above the word "PHARMACEUTICALS". A left pointing arrow head is positioned at the base of the letter "D" of "DICERNA", splicing the double helix.
Goods and ServicesPharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesResearch and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 24, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 24, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDicerna Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Party NameDicerna Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events


Event DateEvent Description
Wednesday, May 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 31, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021SOU EXTENSION 5 GRANTED
Thursday, June 10, 2021SOU EXTENSION 5 FILED
Wednesday, June 16, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 10, 2021TEAS EXTENSION RECEIVED
Thursday, February 25, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 25, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 25, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 11, 2020SOU EXTENSION 4 GRANTED
Friday, December 11, 2020SOU EXTENSION 4 FILED
Friday, December 11, 2020TEAS EXTENSION RECEIVED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 17, 2020SOU EXTENSION 3 GRANTED
Wednesday, June 17, 2020SOU EXTENSION 3 FILED
Wednesday, June 17, 2020TEAS EXTENSION RECEIVED
Friday, December 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 11, 2019SOU EXTENSION 2 GRANTED
Wednesday, December 11, 2019SOU EXTENSION 2 FILED
Wednesday, December 11, 2019TEAS EXTENSION RECEIVED
Friday, June 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2019SOU EXTENSION 1 GRANTED
Wednesday, June 19, 2019SOU EXTENSION 1 FILED
Wednesday, June 19, 2019TEAS EXTENSION RECEIVED
Monday, June 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, September 23, 2018ASSIGNED TO LIE
Saturday, September 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 8, 2018EXAMINER'S AMENDMENT ENTERED
Saturday, September 8, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, September 8, 2018EXAMINERS AMENDMENT E-MAILED
Saturday, September 8, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, September 7, 2018ASSIGNED TO EXAMINER
Friday, May 25, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 24, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 19, 2018NEW APPLICATION ENTERED IN TRAM